Defiance KSM Israel 120 ETF financials
$24.21−1.60%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — |
| Operating income | -$1.2M | -$1.4M | -$1.0M |
| Net income | -$164.9K | -$119.2K | $9.7M |
| Net margin | — | — | — |
| Diluted EPS | $-0.22 | $-0.16 | $0.71 |
| EBITDA | -$534.5K | -$661.9K | -$1.0M |
| Operating cash flow | -$258.3K | $3.3M | -$363.1K |
| Free cash flow | -$258.3K | $3.3M | -$363.1K |
| Diluted shares | 0.8M | 0.8M | 13.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & equivalents | $6.9K | $21.3K | $671.6K |
| Short-term investments | $0.00 | $0.00 | $0.00 |
| Total debt | $1.9M | $825.0K | $0.00 |
| Total assets | $10.0M | $82.6M | $154.5M |
| Total liabilities | $8.0M | $6.9M | $5.7M |
| Shareholders' equity | -$8.0M | -$6.9M | -$4.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology